These Patients May Be Less Adherent to nAMD Treatment

by Medscape • 2024/10/17 • 0 Comments

Patients with neovascular age-related macular degeneration diagnosed by a primary care clinician may be more likely to miss anti-VEGF treatments.
Medscape Medical News

← Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), Continues Its Introduction of LACRIFILL® Canalicular Gel, a Novel Therapy for Dry Eye, During American Academy of Ophthalmology (AAO) 2024

Vision customization with Light Adjustable Lens delivers premium refractive outcome →

Post navigation